All Relations between Multiple Sclerosis and oligodendrocyte

Publication Sentence Publish Date Extraction Date Species
Simone Mader, Samantha Ho, Hoi Kiu Wong, Selia Baier, Stephan Winklmeier, Carolina Riemer, Heike Rübsamen, Iris Marti Fernandez, Ramona Gerhards, Cuilian Du, Omar Chuquisana, Jan D Lünemann, Anja Lux, Falk Nimmerjahn, Monika Bradl, Naoto Kawakami, Edgar Mein. Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 13. 2023-03-21. PMID:36943883. autoantibodies against myelin oligodendrocyte glycoprotein (mog) have recently been established to define a new disease entity, mog-antibody-associated disease (mogad), which is clinically overlapping with multiple sclerosis. 2023-03-21 2023-08-14 human
Susanna Asseyer, Nasrin Asgari, Jeffrey Bennett, Omer Bialer, Yolanda Blanco, Francesca Bosello, Anna Camos-Carreras, Edgar Carnero Contentti, Sara Carta, John Chen, Claudia Chien, Mashina Chomba, Russell C Dale, Josep Dalmau, Kristina Feldmann, Eoin P Flanagan, Caroline Froment Tilikete, Carolina Garcia-Alfonso, Joachim Havla, Mark Hellmann, Ho Jin Kim, Philipp Klyscz, Frank Konietschke, Chiara La Morgia, Marco Lana-Peixoto, Maria Isabel Leite, Netta Levin, Michael Levy, Sara Llufriu, Pablo Lopez, Itay Lotan, Alessandra Lugaresi, Romain Marignier, Sara Mariotto, Susan P Mollan, Cassandra Ocampo, Frederike Cosima Oertel, Maja Olszewska, Jacqueline Palace, Lekha Pandit, José Luis Peralta Uribe, Sean Pittock, Sudarshini Ramanathan, Natthapon Rattanathamsakul, Albert Saiz, Sara Samadzadeh, Bernardo Sanchez-Dalmau, Deanna Saylor, Michael Scheel, Tanja Schmitz-Hübsch, Jemal Shifa, Sasitorn Siritho, Pia S Sperber, Prem S Subramanian, Alon Tiosano, Adi Vaknin-Dembinsky, Alvaro Jose Mejia Vergara, Adi Wilf-Yarkoni, Luis Alfonso Zarco, Hanna G Zimmermann, Friedemann Paul, Hadas Stiebel-Kalis. The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis. Frontiers in neurology. vol 14. 2023-03-13. PMID:36908609. optic neuritis (on) often occurs at the presentation of multiple sclerosis (ms), neuromyelitis optica spectrum disorders (nmosd), and myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad). 2023-03-13 2023-08-14 Not clear
Weifeng Li, Cynthia Berlinicke, Yinyin Huang, Stefanie Giera, Anna G McGrath, Weixiang Fang, Chaoran Chen, Felipe Takaesu, Xiaoli Chang, Yukan Duan, Dinesh Kumar, Calvin Chang, Hai-Quan Mao, Guoqing Sheng, James C Dodge, Hongkai Ji, Stephen Madden, Donald J Zack, Xitiz Chamlin. High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells. iScience. vol 26. issue 3. 2023-02-28. PMID:36852281. promoting myelination capacity of endogenous oligodendrocyte precursor cells (opcs) is a promising therapeutic approach for cns demyelinating disorders such as multiple sclerosis (ms). 2023-02-28 2023-08-14 human
W Doelman, R C Reijnen, N Dijksman, A P A Janssen, N van Driel, B A 't Hart, I Philippens, C Araman, W Baron, S I van Kastere. Citrullinated human and murine MOG The Journal of biological chemistry. 2023-02-25. PMID:36841486. citrullinated human and murine mog the peptide spanning residues 35-55 of the protein myelin oligodendrocyte glycoprotein (mog) has been studied extensively in its role as a key autoantigen in the neuroinflammatory autoimmune disease multiple sclerosis (ms). 2023-02-25 2023-08-14 human
Liuyu Lin, Meihua Ji, Yuqing Wu, Hailun Hang, Jie L. Neutrophil to lymphocyte ratio may be a useful marker in distinguishing MOGAD and MS and platelet to lymphocyte ratio associated with MOGAD activity. Multiple sclerosis and related disorders. vol 71. 2023-02-24. PMID:36827875. clinical overlap is observed between multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein immunoglobulin-g (mog-igg) associated disease (mogad) and the difficulty in distinguishing between the two diseases. 2023-02-24 2023-08-14 Not clear
Yu-Han Gao, Xing L. Cholesterol metabolism: Towards a therapeutic approach for multiple sclerosis. Neurochemistry international. vol 164. 2023-02-22. PMID:36803679. in this review, we provide a detailed overview on brain cholesterol metabolism in multiple sclerosis and its role in promoting oligodendrocyte precursor cell differentiation and remyelination. 2023-02-22 2023-08-14 Not clear
Sohyeon Kim, Hung Youl Seo. Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023-02-13. PMID:36781562. vaccination against the coronavirus disease 2019 (covid-19) is recommended for patients with multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2023-02-13 2023-08-14 Not clear
Andrey E Urusov, Anna S Tolmacheva, Kseniya S Aulova, Georgy A Nevinsk. Autoantibody-Abzymes with Catalase Activity in Experimental Autoimmune Encephalomyelitis Mice. Molecules (Basel, Switzerland). vol 28. issue 3. 2023-02-11. PMID:36770997. at the same time, the development in c57bl/6 mice of experimental autoimmune encephalomyelitis (eae, simulating human multiple sclerosis) happens as a result of the violation of bone marrow hematopoietic stem cell differentiation profiles integrated with the production of toxic auto-antibodies splitting the basic myelin protein, myelin oligodendrocyte glycoprotein (mog), histones, and dna. 2023-02-11 2023-08-14 mouse
Nicolas Daviaud, Eric Chen, Tara Edwards, Saud A Sadi. Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect. Biology open. 2023-02-06. PMID:36744877. cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect. 2023-02-06 2023-08-14 human
Brenda Banwell, Jeffrey L Bennett, Romain Marignier, Ho Jin Kim, Fabienne Brilot, Eoin P Flanagan, Sudarshini Ramanathan, Patrick Waters, Silvia Tenembaum, Jennifer S Graves, Tanuja Chitnis, Alexander U Brandt, Cheryl Hemingway, Rinze Neuteboom, Lekha Pandit, Markus Reindl, Albert Saiz, Douglas Kazutoshi Sato, Kevin Rostasy, Friedemann Paul, Sean J Pittock, Kazuo Fujihara, Jacqueline Palac. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet. Neurology. 2023-01-27. PMID:36706773. serum antibodies directed against myelin oligodendrocyte glycoprotein (mog) are found in patients with acquired cns demyelinating syndromes that are distinct from multiple sclerosis and aquaporin-4-seropositive neuromyelitis optica spectrum disorder. 2023-01-27 2023-08-14 Not clear
Mercedeh Farhat Sabet, Sumanta Barman, Mathias Beller, Sven G Meuth, Nico Melzer, Orhan Aktas, Norbert Goebels, Tim Prozorovsk. Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity. International journal of molecular sciences. vol 24. issue 1. 2023-01-08. PMID:36613687. anti-nmda receptor (nmdar) encephalitis is frequently associated with demyelinating disorders (e.g., multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein-associated disease (mogad)) with regard to clinical presentation, neuropathological and cerebrospinal fluid findings. 2023-01-08 2023-08-14 Not clear
Jorge Guzmán, Francisco Vera, Bernardita Soler, Reinaldo Uribe-San-Martin, Lorena García, Adolfo Del-Canto, Andrea Schlatter, Mauricio Salazar, Fernando Molt, Karla Ramirez, José Marín, Carolina Pelayo, Juan Pablo Cruz, Sebastián Bravo-Grau, Claudia Cárcamo, Ethel Ciamp. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging cases. Multiple sclerosis and related disorders. vol 69. 2022-12-15. PMID:36521387. anti-myelin oligodendrocyte glycoprotein (mog) antibody associated disease (mogad) is an emerging disorder recognized as a clinical entity distinct from multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorders (nmosd-aqp4+), and its phenotypic spectrum continues to expand. 2022-12-15 2023-08-14 Not clear
Itay Lotan, Thibo Billiet, Annemie Ribbens, Wim Van Hecke, Benny Huang, Ilya Kister, Eyal Lota. Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis. Multiple sclerosis and related disorders. vol 69. 2022-12-13. PMID:36512956. relatively little is known about how global and regional brain volumes changes in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) compare with multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and healthy controls (hc). 2022-12-13 2023-08-14 Not clear
Hadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, Alon Tiosano, Itay Lotan, Mark A Hellmann, Adi Wilf-Yarkoni, Omer Bialer, Eoin P Flanagan, Sean J Pittock, M Tariq Bhatti, Tanja Schmitz-Hübsch, Paul Friedemann, Susanna Asseyer, John J Che. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Scientific reports. vol 12. issue 1. 2022-12-09. PMID:36494385. optic neuritis (on) is a frequent presentation at onset of multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). 2022-12-09 2023-08-14 Not clear
Giulia Fadda, Eoin P Flanagan, Laura Cacciaguerra, Jiraporn Jitprapaikulsan, Paolo Solla, Pietro Zara, Elia Sech. Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD. Frontiers in neurology. vol 13. 2022-11-24. PMID:36419536. three main demyelinating disorders of the central nervous system, namely multiple sclerosis (ms), aquaporin-4-igg-positive neuromyelitis optica spectrum disorders (aqp4+nmosd) and myelin oligodendrocyte glycoprotein-igg associated disease (mogad), can induce spinal cord inflammation through different pathogenic mechanisms, resulting in a more or less profound disruption of spinal cord integrity. 2022-11-24 2023-08-14 Not clear
Neda Karami, Hadi Aligholi, Moosa Rahimi, Hassan Azari, Tahereh Kalantar. G Protein Coupled Receptors Potentially Involved in Oligodendrogenesis: A Gene Expression Analysis. Iranian journal of public health. vol 51. issue 10. 2022-11-23. PMID:36415811. multiple sclerosis (ms) is a chronic demyelinating disease of the central nervous system characterized by infiltration of inflammatory leukocytes to the cns followed by oligodendrocyte cell death, myelin sheath destruction, and axonal injury. 2022-11-23 2023-08-14 Not clear
Dimitrios C Ladakis, Jennifer Gould, Jenny M Khazen, Julia M Lefelar, Scott Tarpey, Charles J Bies, Rebecca Salky, Kathryn C Fitzgerald, Pavan Bhargava, Bardia Nourbakhsh, Elias S Sotircho. Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease. Multiple sclerosis journal - experimental, translational and clinical. vol 8. issue 4. 2022-11-21. PMID:36407471. unlike multiple sclerosis and neuromyelitis optica, the burden of fatigue in myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is unclear. 2022-11-21 2023-08-14 Not clear
Ali Jahanbazi Jahan-Abad, Hannah E Salapa, Cole D Libner, Patricia A Thibault, Michael C Levi. hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis. Glia. 2022-11-16. PMID:36382566. oligodendrocyte (ol) damage and death are prominent features of multiple sclerosis (ms) pathology, yet mechanisms contributing to ol loss are incompletely understood. 2022-11-16 2023-08-14 mouse
Adrian Budhram, Ario Mirian, Manas Sharm. Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum. Frontiers in neurology. vol 13. 2022-11-07. PMID:36341089. myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) is an inflammatory demyelinating disease that is distinct from multiple sclerosis. 2022-11-07 2023-08-14 Not clear
Thomas Garton, Alexander J Gill, Peter A Calabres. Distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis. Brain : a journal of neurology. 2022-11-03. PMID:36325693. distinct mechanisms of oligodendrocyte injury inform therapeutic interventions in multiple sclerosis. 2022-11-03 2023-08-14 Not clear